Table 2.
| Criteria and description | ||
|---|---|---|
| Mandatory | Major | Minor |
|
Documented fat scarcity by: A. Skinfold measurement on the thigh (≤ 10 mm for men and ≤ 20 mm for women) [11, 20] OR B. Dual-energy X-ray absorptiometry (DXA) with a fat mass ratio (FMR) > 1.2 [34] OR C. Lower limbs fat mass < 25% of total body fat (also via DXA), after exclusion of other causes [12] |
A. First-degree relative with a documented diagnosis of familial partial lipodystrophy (via genetic or clinical diagnosis) B. Severe hypertriglyceridemia (≥ 500 mg/dL) or acute pancreatitis due to hypertriglyceridemia C. Diabetes, impaired fasting glucose, or glucose intolerance D. Metabolic dysfunction-associated steatotic liver disease |
Clinical history A. Family history of acute pancreatitis secondary to hypertriglyceridemia B. Polycystic ovary syndrome C. First-degree family history of diabetes mellitus or hypertriglyceridemia (diagnosed before age 40) D. Personal or family history of early coronary artery disease (in the patient or first-degree relative) E. Systemic hypertension diagnosed before age 40 Laboratory tests A. Triglycerides between 150 and 499 mg/dL and/or high-density lipoprotein < 50 mg/dL (women) or < 40 mg/dL (men), B. Hypoleptinemia (< 8 ng/mL in men and < 12 ng/mL in women) [83, 90] Physical examination A. Normal body mass index or overweight (BMI < 30 kg/m2) B. Waist-to-hip ratio > 0.85 (women) and > 0.95 (men) C. Acanthosis nigricans D. Prominent muscularity of the limbs E. Fat deposition in the suprapubic, cervical, and/or submandibular regions (double chin sign) and filling of the supraclavicular área |